LV12082B - DEVICE FOR CONTROL OF MEDICAL SUBSTANCES CONTROLLED - Google Patents

DEVICE FOR CONTROL OF MEDICAL SUBSTANCES CONTROLLED Download PDF

Info

Publication number
LV12082B
LV12082B LVP-98-50A LV980050A LV12082B LV 12082 B LV12082 B LV 12082B LV 980050 A LV980050 A LV 980050A LV 12082 B LV12082 B LV 12082B
Authority
LV
Latvia
Prior art keywords
core
polymer
hydration
aģent
release
Prior art date
Application number
LVP-98-50A
Other languages
English (en)
Latvian (lv)
Other versions
LV12082A (lv
Inventor
Gerald S. Rork
James D. Pipkin
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of LV12082A publication Critical patent/LV12082A/xx
Publication of LV12082B publication Critical patent/LV12082B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LVP-98-50A 1991-12-27 1998-03-12 DEVICE FOR CONTROL OF MEDICAL SUBSTANCES CONTROLLED LV12082B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81530491A 1991-12-27 1991-12-27
US90218892A 1992-07-29 1992-07-29

Publications (2)

Publication Number Publication Date
LV12082A LV12082A (lv) 1998-07-20
LV12082B true LV12082B (en) 1998-09-20

Family

ID=27123932

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-98-50A LV12082B (en) 1991-12-27 1998-03-12 DEVICE FOR CONTROL OF MEDICAL SUBSTANCES CONTROLLED

Country Status (26)

Country Link
EP (1) EP0549331B1 (hu)
JP (1) JPH089534B2 (hu)
KR (1) KR100281609B1 (hu)
CN (1) CN1074368A (hu)
AT (1) ATE157001T1 (hu)
AU (1) AU660057B2 (hu)
BG (1) BG61751B1 (hu)
CA (1) CA2085871C (hu)
CZ (1) CZ284045B6 (hu)
DE (1) DE69221711T2 (hu)
DK (1) DK0549331T3 (hu)
ES (1) ES2106838T3 (hu)
FI (1) FI109451B (hu)
GR (1) GR3024885T3 (hu)
HU (1) HU219594B (hu)
IL (1) IL104189A (hu)
LV (1) LV12082B (hu)
MX (1) MX9207541A (hu)
NO (1) NO310672B1 (hu)
NZ (1) NZ245514A (hu)
PL (1) PL171110B1 (hu)
RO (1) RO112810B1 (hu)
RU (1) RU2127586C1 (hu)
SK (1) SK279964B6 (hu)
WO (1) WO1993012765A1 (hu)
YU (1) YU48762B (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582838A (en) * 1994-12-22 1996-12-10 Merck & Co., Inc. Controlled release drug suspension delivery device
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
KR100503266B1 (ko) * 1997-01-14 2005-07-25 에르테에스 로만 테라피-시스테메 게엠베하 운트 코. 카게 위장관 내의 활성물질 방출을 조절하는, 팽창가능한 위장 체류성 치료장치
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6506397B1 (en) * 1999-02-19 2003-01-14 Curt Thies Pest controlling
ATE244558T1 (de) 1999-04-16 2003-07-15 Novo Nordisk As Trockene formbare arzneistoffformulierung
AU2001276748A1 (en) * 2000-08-08 2002-02-18 Daiichi Pharmaceutical Co., Ltd. Highly absorbable solid preparation
EP1349531A1 (en) 2001-01-12 2003-10-08 Sun Pharmaceuticals Industries Ltd. Spaced drug delivery system
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
JP4615862B2 (ja) * 2001-12-18 2011-01-19 ノボ・ノルデイスク・エー／エス 固形投与マイクロインプラント
US20030153617A1 (en) * 2001-12-18 2003-08-14 Dalen Frans Van Simvastatin dosage forms
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
ES2355233T3 (es) * 2002-09-28 2011-03-24 Mcneil-Ppc, Inc. Formas de dosificación de liberación modificada con dos núcleos y una abertura.
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
JP2008504938A (ja) 2004-07-02 2008-02-21 レイザー，エリオット 治療媒体送出装置およびその送出装置を用いて治療媒体を眼に送り出す方法
BRPI0709672B8 (pt) 2006-03-31 2021-06-22 3088922 Inc implante ocular insersível em um lúmen ocular e método de distribuição de um agente terapêutico a um olho
KR20100067099A (ko) 2007-09-07 2010-06-18 큐엘티 플러그 딜리버리, 인코포레이티드 눈물 임플랜트 검출
EP3290024B1 (en) 2011-08-29 2019-04-17 Mati Therapeutics Inc. Sustained release delivery of active agents to treat glaucoma and ocular hypertension
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
JP2020066606A (ja) * 2018-10-25 2020-04-30 株式会社ダイセル １型ヘルパーｔ細胞増加剤、食品、及び医薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5057321A (en) * 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin

Also Published As

Publication number Publication date
PL171110B1 (pl) 1997-03-28
FI109451B (fi) 2002-08-15
CA2085871A1 (en) 1993-06-28
AU3034892A (en) 1993-08-12
IL104189A (en) 1996-10-31
CN1074368A (zh) 1993-07-21
HUT70437A (en) 1995-10-30
ATE157001T1 (de) 1997-09-15
NZ245514A (en) 1994-12-22
NO942430D0 (no) 1994-06-27
HU219594B (hu) 2001-05-28
JPH089534B2 (ja) 1996-01-31
EP0549331A1 (en) 1993-06-30
SK279964B6 (sk) 1999-06-11
BG61751B1 (bg) 1998-05-29
HU9401913D0 (en) 1994-09-28
KR940703653A (ko) 1994-12-12
CA2085871C (en) 2002-05-07
RU2127586C1 (ru) 1999-03-20
AU660057B2 (en) 1995-06-08
WO1993012765A1 (en) 1993-07-08
LV12082A (lv) 1998-07-20
DK0549331T3 (da) 1997-09-15
DE69221711D1 (de) 1997-09-25
EP0549331B1 (en) 1997-08-20
FI943011A0 (fi) 1994-06-22
MX9207541A (es) 1994-06-30
GR3024885T3 (en) 1998-01-30
DE69221711T2 (de) 1998-03-12
SK76994A3 (en) 1995-05-10
CZ284045B6 (cs) 1998-07-15
IL104189A0 (en) 1993-05-13
ES2106838T3 (es) 1997-11-16
RU94031474A (ru) 1997-04-20
NO942430L (no) 1994-06-27
JPH05255071A (ja) 1993-10-05
RO112810B1 (ro) 1998-01-30
NO310672B1 (no) 2001-08-13
KR100281609B1 (ko) 2001-02-15
FI943011A (fi) 1994-06-22
CZ157094A3 (en) 1994-12-15
YU111292A (sh) 1995-12-04
BG98805A (bg) 1995-03-31
YU48762B (en) 1999-11-22

Similar Documents

Publication Publication Date Title
US5366738A (en) Controlled release drug dispersion delivery device
US5543154A (en) Controlled release nifedipine delivery device
AU693313B2 (en) A controlled release drug suspension delivery device
EP0549331B1 (en) Controlled release drug dispersion delivery device
US5869097A (en) Method of therapy comprising an osmotic caplet
MXPA97004672A (en) Device supplier of suspension of farmaco, control deliberation
CA2269707C (en) Soluble form osmotic dose delivery system
CA2206211C (en) A controlled release drug suspension delivery device